⌘K
Loading ticker…
Design Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Design Therapeutics, Inc. Common Stock (DSGN) has a 3-month relative strength percentile of 76 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 76. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.2%, relative volume 3.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 76, Market Stance is mixed at 47, A/D rating E
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
DSGN is in a stage 2 uptrend, week 2. Currently in a 40-day base; basing ADR 8.6% (broad 5.3%). VCP detected: 3 contractions. RS line below base-start high. Distance from 50d / 200d: 7.3% / 36.5%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
DSGN is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $10M notional. Top 3 carry $20M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $10M |
| IWMiShares Russell 2000 ETF | 0.01% | $6M |
| VXFVanguard Extended Market ETF | 0.00% | $4M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DSGN Jan avg: -11.65% median: -15.98% win: 25% σ: 14.79% n: 4 2022-04-12 → 2026-05-29 | DSGN Feb avg: 2.46% median: 1.23% win: 75% σ: 11.24% n: 4 2022-04-12 → 2026-05-29 | DSGN Mar avg: 1.98% median: -8.24% win: 50% σ: 30.39% n: 4 2022-04-12 → 2026-05-29 | DSGN Apr avg: 6.49% median: 11.79% win: 60% σ: 22.08% n: 5 2022-04-12 → 2026-05-29 | DSGN May avg: -7.87% median: -12.71% win: 40% σ: 17.08% n: 5 2022-04-12 → 2026-05-29 | DSGN Jun avg: -0.71% median: 1.13% win: 50% σ: 15.05% n: 4 2022-04-12 → 2026-05-29 (current) | DSGN Jul avg: 34.11% median: 34.67% win: 100% σ: 15.92% n: 4 2022-04-12 → 2026-05-29 | DSGN Aug avg: -7.56% median: -1.80% win: 50% σ: 46.56% n: 4 2022-04-12 → 2026-05-29 | DSGN Sep avg: 6.78% median: 4.21% win: 50% σ: 23.30% n: 4 2022-04-12 → 2026-05-29 | DSGN Oct avg: -8.44% median: -8.80% win: 0% σ: 4.84% n: 4 2022-04-12 → 2026-05-29 | DSGN Nov avg: 15.48% median: 16.07% win: 75% σ: 20.68% n: 4 2022-04-12 → 2026-05-29 | DSGN Dec avg: -3.39% median: 1.36% win: 50% σ: 16.17% n: 4 2022-04-12 → 2026-05-29 |